Docket Management
Docket: 02N-0209 - Request for Comment on First Amendment Issues
Comment Number: EC -99

Accepted - Volume 2

Comment Record
Commentor Ms. Marcia Slatkin Date/Time 2002-06-01 23:40:56
Organization Ms. Marcia Slatkin
Category Individual

Comments for FDA General
Questions
9. Are there any regulations, guidance, policies, and practices FDA should change, in light of governing First Amendment authority? The FDA should not require labels on supplements to carry a disclaimer as to efficacy. The provider of the supplement should be able to indicate clearly to the consumer the purpose of the supplement, and the way to most efficiently take the supplement -- i.e. the dose. If the FDA wants to tell the consumer that the ingredients have not been evaluated by its offices, do so in small letters that do not in any way obscure the primary message about relevant conditions the supplement is helpful in treating, common dosages, etc. Please do not get in the way of the public's right to freely spoken information. Thank you.




EC -99